netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Results

Looking for Bortezomib found 15 matches
Open monograph to display formulary status BNF Category
  Cytotoxic Drug Bortezomib Malignant disease and immunosuppression - Bortezomib - 08.01.05
  Cytotoxic Drug Daratumumab  (Darzalex®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
  Lenalidomide Malignant disease and immunosuppression - Lenalidomide, pomalidomide, and thalidomide - 08.02.04
  Cytotoxic Drug Panobinostat Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
  Pomalidomide  (Imnovid®) Malignant disease and immunosuppression - Lenalidomide, pomalidomide, and thalidomide - 08.02.04
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section NICE TA129: Multiple myeloma - bortezomib (08.01.05)
link in drug section NICE TA228: Bortezomib and thalidomide for the first‑line treatment of multiple myeloma (08.01.05)
link in drug section NICE TA228: Bortezomib and thalidomide for the first‑line treatment of multiple myeloma (08.02.04)
link in drug section NICE TA311: Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation (08.01.05)
link in drug section NICE TA370: Bortezomib for previously untreated mantle cell lymphoma (08.01.05)
link in drug section NICE TA427: Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib (08.01.05)
link in drug section NICE TA427: Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib (08.02.04)
link in drug section NICE TA586: Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib (08.02.04)
link in drug section NICE TA897: Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma (08.01.05)

SubSection Titles / notes  
Bortezomib - (08.01.05)

 
netFormulary